Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

1571 - 1580 of 44782 results found

Anemoside B4 inhibits SARS-CoV-2 replication in vitro and in vivo

Date
Tuesday, February 20, 2024 - 4:00 AM
Description
CONCLUSION: Our results indicated that AB4 inhibited SARS-CoV-2 replication through the RLR pathways and moderated the RNA metabolism, suggesting that it would be a potential lead compound for the development of anti-SARS-CoV-2 drugs.